Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroprotection by dopamine agonists

K W Lange1, W D Rausch, W Gsell

  • 1Laboratory of Clinical Neurochemistry, University of Würzburg, Federal Republic of Germany.

Journal of Neural Transmission. Supplementum
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of computed tomography and bioelectrical impedance analysis for measuring body composition in patients with esophageal cancer: A retrospective cohort study.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same author

Long-term evaluation of post restorations: Results from a practice-based study with up to 20 years of follow-up.

Journal of dentistry·2025
Same author

Long-term success and survival of post-endodontic restorations without posts after up to 18 years: A practice-based study.

Journal of dentistry·2025
Same author

Supplementary orthopaedic screening for children and adolescents to prevent permanent skeletal deformities - protocol for the "OrthoKids" study.

BMC musculoskeletal disorders·2023
Same author

Effect of apical root resection, orthodontic extrusion, and surgical crown lengthening on load capability.

Clinical oral investigations·2023
Same author

[Spontaneous intracranial hypotension with brain sagging and reversible frontotemporal dementia : Case report and review of the literature].

Der Nervenarzt·2022

Dopamine agonists like bromocriptine show promise in preventing neurodegeneration in Parkinson's disease models. Further research is needed to confirm if these effects are neuroprotective or symptomatic.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurodegenerative diseases

Background:

  • Parkinson's disease pathogenesis involves oxidative stress, impaired mitochondrial function, and altered iron metabolism.
  • Neuroprotection strategies aim to prevent or slow Parkinson's disease progression.

Purpose of the Study:

  • To investigate the neuroprotective potential of dopamine agonists in Parkinson's disease.
  • To explore novel therapeutic strategies for Parkinson's disease and aging.

Main Methods:

  • Administration of dopamine agonists (pergolide, bromocriptine, lisuride) in animal models.
  • Assessment of neuroprotection against MPTP-induced neurotoxicity.
  • Comparison of lisuride monotherapy with L-deprenyl in early Parkinson's disease.

Related Experiment Videos

Main Results:

  • Pergolide preserved nigrostriatal neurons in aging rats.
  • Bromocriptine prevented striatal dopamine reduction after MPTP administration in mice.
  • Lisuride monotherapy delayed levodopa initiation in early Parkinson's disease.

Conclusions:

  • Dopamine agonists may offer neuroprotection against neurotoxins and aging-related degeneration.
  • Bromocriptine demonstrates potential in preventing MPTP-induced neurotoxicity.
  • Further studies are required to elucidate the mechanisms of dopamine agonist efficacy in Parkinson's disease.